Micrus expands offerings with exclusive Biotronik deal
This article was originally published in Clinica
Executive Summary
Consistent with its strategy to bulk up its product portfolio, Micrus Endovascular has secured an exclusive worldwide agreement to distribute novel neurovascular devices for treating haemorrhagic and ischaemic stroke, which it would jointly develop with Swiss medical device company Biotronik.